RIVA, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 6.027
EU - Europa 4.602
AS - Asia 2.313
SA - Sud America 283
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 4
Totale 13.272
Nazione #
US - Stati Uniti d'America 5.973
IT - Italia 2.230
UA - Ucraina 799
SG - Singapore 756
CN - Cina 465
TR - Turchia 383
SE - Svezia 344
VN - Vietnam 313
DE - Germania 309
HK - Hong Kong 266
BR - Brasile 254
FI - Finlandia 217
IE - Irlanda 203
FR - Francia 151
GB - Regno Unito 139
RU - Federazione Russa 110
IN - India 37
CA - Canada 29
JP - Giappone 24
BE - Belgio 20
NL - Olanda 20
MX - Messico 19
BD - Bangladesh 17
PL - Polonia 16
EU - Europa 13
ZA - Sudafrica 13
AR - Argentina 11
IQ - Iraq 9
SA - Arabia Saudita 7
AT - Austria 6
CH - Svizzera 6
LT - Lituania 6
ES - Italia 5
ID - Indonesia 5
UZ - Uzbekistan 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
PK - Pakistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HR - Croazia 3
KE - Kenya 3
MA - Marocco 3
NP - Nepal 3
OM - Oman 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.272
Città #
Milan 1.565
Jacksonville 608
Chandler 586
Fairfield 578
Ashburn 390
Woodbridge 388
Singapore 370
Dearborn 317
Ann Arbor 280
Hong Kong 266
Houston 251
Wilmington 251
Princeton 214
Seattle 203
Dublin 201
Izmir 190
Beijing 186
Nyköping 183
Cambridge 171
Dallas 139
Boardman 127
Rome 113
Dong Ket 110
San Mateo 88
New York 85
Los Angeles 77
The Dalles 73
Como 71
Munich 53
San Diego 50
Chicago 47
Ogden 41
Ho Chi Minh City 32
Buffalo 29
Hefei 28
São Paulo 24
Tokyo 23
Kunming 20
London 19
Santa Clara 19
Turku 18
Brussels 17
Nanjing 17
Hanoi 16
Guangzhou 15
Jinan 15
Verona 15
Poplar 14
Warsaw 14
Denver 13
Norwalk 13
Chennai 12
Düsseldorf 12
Nanchang 12
Washington 11
Frankfurt am Main 10
Phoenix 10
San Francisco 10
Atlanta 9
Boston 9
Brooklyn 9
Montreal 9
Toronto 9
Helsinki 8
Johannesburg 8
Manchester 8
Orem 8
Amsterdam 7
Ankara 7
Casorezzo 7
Catania 7
Fuzhou 7
Mexico City 7
Pune 7
Shenyang 7
Auburn Hills 6
Campinas 6
Changsha 6
Redwood City 6
Rio de Janeiro 6
Stockholm 6
Vienna 6
Belo Horizonte 5
Biên Hòa 5
Council Bluffs 5
Kocaeli 5
Nuremberg 5
Querétaro 5
Salt Lake City 5
Tashkent 5
Baghdad 4
Cape Town 4
Charlotte 4
Chengdu 4
Edinburgh 4
Florence 4
Indiana 4
Mountain View 4
New Delhi 4
Providence 4
Totale 8.965
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 270
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO 263
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics 230
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses 226
Carcinosarcoma of the uterine cervix: Case report and discussion. 214
Inherited cancer syndromes in 220 Italian ovarian cancer patients 212
Natural history of cervical intraepithelial neoplasia during pregnancy. 205
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 205
Biochemical and immunohistochemical characterization of human RNASET2 expression 201
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome 201
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes 199
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling 199
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis 193
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis 191
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers 184
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case 175
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature. 171
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature 171
Identifying factors contributing to reduced breast tumor size: A longitudinal study 165
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis 163
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences 157
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene 153
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors 150
Early Involvement of 6q in Surface Epithelial Ovarian Tumors 149
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas 146
Disorders of the Endocrine System 141
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours 140
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy 140
CD44 expression in ER and PR negative ductal breast carcinomas 138
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study 138
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 136
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms. 134
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas 132
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms 130
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999 130
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis 126
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. 126
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids 126
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. 126
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001 125
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 124
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 124
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS 123
Fetoplacental cytomegalovirus infection. A case report 122
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts 122
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I 121
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 120
Diabetic fibrous mastopathy: sonographic-pathologic correlation 120
Androgen receptors in breast 120
Microsatellite instability in endometrial cancer. Relation to histological subtypes 119
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA 118
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 118
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas 116
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE 115
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. 114
Prognostic significance of karyotype analysis in ovarian carcinomas 113
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia 111
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 110
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI 110
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology 109
Clinicopathological features of oral carcinoma: analysis of 240 cases 108
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 106
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas 105
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 104
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas” 102
RNASET2 is a non-cell autonomous human tumor suppressor 102
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 102
Espressione del recettore degli androgeni nel carcinoma mammario 100
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas. 100
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases. 99
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms 98
Pituitary adenomas, a thirty-four-years experience in a –single institution. 98
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas 98
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas 96
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 95
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas. 94
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study 94
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis 94
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers 92
The applications of FISH in tumor pathology 92
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas 92
Capitolo 9.7: Intestino tenue 91
IL CARCINOMA MICROINVASIVO DELLA CERVICE 90
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT 90
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST 89
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis 88
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS 87
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression 86
Prognostic significance of karyotype analysis in ovarian carcinomas 85
Molecular genetics of syncronous endometrial and ovarian carcinomas 85
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas. 84
p53 positive, breast cancers frequently express basal and myoepithelial cell markers 82
Expression of gastrointestinal markers in pancreatic carcinomas 82
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento 81
Capitolo 9.6: Stomaco 81
Clinicopathological features of neuroendocrine carcinomas (NECs) of the breast 80
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale. 78
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION 76
Classification and histogenesis of gastroenteropancreatic endocrine tumors. 76
Capitolo 9.8: Colon-retto 76
Totale 12.788
Categoria #
all - tutte 52.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021995 0 0 0 0 0 162 50 130 228 65 145 215
2021/20221.054 106 126 96 76 46 37 37 69 53 161 83 164
2022/20231.460 127 99 105 195 91 299 3 201 219 35 59 27
2023/20242.348 394 388 400 413 470 149 9 17 57 16 17 18
2024/20251.448 9 21 264 41 49 59 50 81 214 113 137 410
2025/20261.578 263 221 121 569 361 43 0 0 0 0 0 0
Totale 13.338